Saltar al contenido
Merck

Diagnosis and treatment of diffuse large B-cell lymphoma in an orangutan (Pongo pygmaeus).

Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians (2015-01-31)
Offiong F Ikpatt, Drury Reavill, Jason Chatfield, Susan Clubb, Joseph D Rosenblatt, Glenn Fonte, Yao-Shan Fan, Carolyn Cray
RESUMEN

Lymphoma is a common malignancy observed in companion animals. This type of naturally occurring neoplasia has been uncommonly reported in great apes. Diffuse large B-cell lymphoma was diagnosed in an 8-yr-old captive orangutan (Pongo pygmaeus) with gastrointestinal disease by histologic and immunohistochemical methodologies. The orangutan was treated with three cycles of combination chemotherapy (intravenous Rituxan, cyclophosphamide, doxorubicin, and vincristine). The primate has been in good health and exhibiting normal behaviors for more than 15 mo following treatment.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
Doxorrubicina hydrochloride, 98.0-102.0% (HPLC)
Sigma-Aldrich
Doxorrubicina hydrochloride, suitable for fluorescence, 98.0-102.0% (HPLC)
USP
Prednisona, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Prednisona, ≥98%
Doxorrubicina hydrochloride, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Vincristine sulfate salt, 95.0-105.0% (HPLC), powder or crystals
Supelco
Prednisona, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Doxorrubicina hydrochloride, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Vincristine sulfate, meets USP testing specifications
Vincristine sulfate, European Pharmacopoeia (EP) Reference Standard